Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 155,972 shares changed hands during trading, an increase of 7% from the previous session’s volume of 145,800 shares.The stock last traded at $153.0470 and had previously closed at $112.19.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 18th. Weiss Ratings cut Nutex Health from a “hold (c-)” rating to a “sell (d)” rating in a research note on Wednesday. Finally, Maxim Group set a $205.00 price target on Nutex Health and gave the stock a “buy” rating in a report on Tuesday, August 26th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Nutex Health presently has an average rating of “Hold” and a consensus price target of $252.50.
Check Out Our Latest Analysis on Nutex Health
Nutex Health Stock Performance
Institutional Investors Weigh In On Nutex Health
Several institutional investors have recently bought and sold shares of the company. Topline Capital Management LLC grew its stake in shares of Nutex Health by 80.0% during the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after acquiring an additional 247,436 shares in the last quarter. Pertento Partners LLP bought a new position in Nutex Health in the third quarter valued at $27,940,000. Vanguard Group Inc. grew its position in Nutex Health by 12.7% in the third quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock valued at $22,209,000 after purchasing an additional 24,275 shares in the last quarter. American Century Companies Inc. increased its stake in Nutex Health by 39.9% in the 2nd quarter. American Century Companies Inc. now owns 104,063 shares of the company’s stock valued at $12,955,000 after buying an additional 29,704 shares during the last quarter. Finally, Marshall Wace LLP lifted its position in Nutex Health by 333.4% during the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock worth $11,770,000 after buying an additional 72,734 shares in the last quarter. Institutional investors own 5.32% of the company’s stock.
About Nutex Health
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
- Five stocks we like better than Nutex Health
- Manufacturing Stocks Investing
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- What is a Special Dividend?
- Attention Income Investors: This REIT Is on Sale
- Insider Buying Explained: What Investors Need to Know
- Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
